Athlete's foot drug could fight prostate cancer recurrence

NCT ID NCT07365423

Summary

This study is testing if terbinafine, a long-approved antifungal medication, can help control prostate cancer that has returned after initial treatment. It aims to delay the need for stronger hormone-blocking therapies, which often cause significant side effects. The trial will involve 42 men whose cancer has returned but hasn't spread to visible tumors, measuring if the drug slows the rise of their PSA levels.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • EOC - Istituto Oncologico della Svizzera Italiana

    Bellinzona, 6500, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • HOCH Health Ostschweiz - Kantonsspital St. Gallen

    Sankt Gallen, 9007, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpitaux Universitaires Genève HUG

    Geneva, 1211, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kantonspital Aarau

    Aarau, CH-5001, Switzerland

  • Kantonsspital Baden

    Baden, 5404, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kantonsspital Graubünden

    Chur, 7000, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Kantonsspital Winterthur

    Winterthur, 8401, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Luzerner Kantonsspital

    Lucerne, 6004, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Spital Thurgau AG

    Frauenfeld, 8501, Switzerland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • TBZO Tumor- und BrustZentrum Ostschweiz - Rapperswil

    Rapperswil, 8640, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Universitätsspital Basel

    Basel, 4031, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Universitätsspital Zürich USZ

    Zurich, 8091, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.